Bedfont® Scientific Limited, an innovative leader in breath analysis and Fractional exhaled Nitric Oxide (FeNO) testing for ...

Asthma is the most common chronic airway disease worldwide, imposing substantial clinical, societal, and economic burden.

Researchers have identified a genetic biomarker of asthma that can be tested for using a simple nasal brush and basic follow-up data analysis. This inexpensive diagnostic test can accurately identify ...

A lung function test used to help diagnose asthma works better in the morning, becoming less reliable throughout the day, Cambridge researchers have found. Using real world data from 1,600 patients, ...

Asthma is one of the most common respiratory diseases worldwide, affecting more than 235 million patients. It is often more difficult to diagnose in children than in adults. An early diagnosis is ...

Test your knowledge on changing approaches to managing patients with asthma outlined in the 2026 GINA asthma update.

Diagnosing mild-to-moderate asthma can be difficult to diagnose, especially when scientists need to rule out other respiratory disorders that have similar symptoms. From Mount Sinai, scientists ...